Ken Griffin Icu Medical Inc Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$94.53 - $120.55 $151,248 - $192,880	1,600 Added 53.33%	4,600 $546,000
Q1 2024 May 15, 2024	BUY	$86.88 - $112.48 $26,064 - $33,744	300 Added 11.11%	3,000 $321,000
Q4 2023 Feb 14, 2024	BUY	$81.08 - $119.29 $170,268 - $250,509	2,100 Added 350.0%	2,700 $269,000
Q3 2023 Nov 14, 2023	SELL	$115.27 - $182.23 $587,877 - $929,373	-5,100 Reduced 89.47%	600 $71,000
Q2 2023 Aug 14, 2023	BUY	$161.03 - $209.15 $354,266 - $460,130	2,200 Added 62.86%	5,700 $1.02 Million
Q1 2023 May 15, 2023	SELL	$153.15 - $198.21 $673,860 - $872,124	-4,400 Reduced 55.7%	3,500 $577,000
Q4 2022 Feb 14, 2023	BUY	$136.25 - $165.56 $381,500 - $463,568	2,800 Added 54.9%	7,900 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$149.44 - $188.1 $762,144 - $959,310	5,100 New	5,100 $768,000

275

24.1M

28.3K

35.5K

Ticker ICUI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 23,899,400
Market Cap $4.33B
Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.